ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 140 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,684,232 | $82,760,731 | 4.94% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,105,309 | $10,533,595 | 3.47% |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $28,590,000 | 2.94% |
| Rubric Capital Management LP | 4,884,530 | $46,549,571 | 1.99% |
| AlphaCentric Advisors LLC | 292,500 | $2,787,525 | 1.55% |
| 1492 Capital Management LLC | 222,767 | $2,122,970 | 1.24% |
| Tejara Capital Ltd | 164,179 | $1,564,626 | 0.77% |
| Sio Capital Management, LLC | 293,047 | $2,792,738 | 0.71% |
| Two Seas Capital LP | 232,201 | $2,212,876 | 0.48% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 872,427 | $8,314,229 | 0.44% |
| Cormorant Asset Management, LP | 800,000 | $7,624,000 | 0.43% |
| Orbimed Advisors | 1,914,479 | $18,244,985 | 0.33% |
| GW&K Investment Management, LLC | 2,062,683 | $19,657 | 0.19% |
| PDT Partners, LLC | 120,578 | $1,149,108 | 0.16% |
| Polar Capital Holdings Plc | 3,127,777 | $29,807,715 | 0.15% |
| Regency Capital Management Inc.\DE | 13,000 | $123,890 | 0.11% |
| Woodline Partners LP | 807,750 | $7,697,858 | 0.09% |
| FISHMAN JAY A LTD/MI | 154,000 | $1,467,620 | 0.09% |
| Symmetry Investments LP | 58,200 | $555 | 0.08% |
| Holocene Advisors, LP | 1,440,036 | $13,723,543 | 0.06% |
External links
This page lists ARCUTIS BIOTHERAPEUTICS INC's shareholders in Q2 2023. To view ARCUTIS BIOTHERAPEUTICS INC's shareholder history, click here.